微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
SR-136683是一种口服制剂，其中含有血管内皮生长因子受体（VEGFR）和血小板衍生生长因子受体（PDGFR）的小分子受体酪氨酸激酶抑制剂，具有潜在的抗肿瘤活性。
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.23 mL | 116.16 mL | 232.31 mL |
| 0.5 mM | 4.65 mL | 23.23 mL | 46.46 mL |
| 1 mM | 2.32 mL | 11.62 mL | 23.23 mL |
| 5 mM | 0.46 mL | 2.32 mL | 4.65 mL |
*The above data is based on the productmolecular weight 430.45258. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A13554 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 430.45258 |
| Formula | C25H22N2O5 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 637774-61-9 |
| Synonyms | SR13668, SR 13668, CHEMBL245030, LS-190469 |
| SMILES | CCOC(=O)C1=CC2=C3C=C4C5=C(C=CC(=C5)C(=O)OCC)NC4=C(C3=NC2=CC1)OC |
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
Palomid 529 (P529)
Palomid 529是PI3K/Akt/mTOR途径的双重TORC1/2抑制剂，在血管生成和细胞增殖中具有广泛的活性。
MK-2206 2HCl
MK-2206 2HCl是Akt1/2/3的高选择性抑制剂，IC50分别为8 nM/12 nM/65 nM。
Triciribine
Triciribine，也称为API-2，可抑制Akt的磷酸化水平和激酶活性。
Triciribine phosphate (NSC-280594)
Triciribine phosphate是一种DNA synthesis抑制剂，也抑制PC3细胞系中的Akt和CEM-SS，H9，H9IIIB，U1细胞中的HIV-1，IC50分…
GSK2141795 (Uprosertib, GSK795)
GSK2141795 (Uprosertib,GSK795)结合并抑制Akt的活性，这可能导致PI3K/Akt信号传导途径的抑制和肿瘤细胞的增殖以及…
Keywords:购买 SR-13668 | SR-13668 供应商 | 订购 SR-13668 | SR-13668 价格 | SR-13668 生产商 | 订单 SR-13668 | SR-13668 代理商 | 购买 637774-61-9| 637774-61-9 供应商 | 订购 637774-61-9 | 637774-61-9 价格 | 637774-61-9 生产商 | 订单 637774-61-9 | 637774-61-9 代理商|buy SR-13668 | SR-13668 Supplier | purchase SR-13668 | SR-13668 cost | SR-13668 manufacturer | order SR-13668 | SR-13668 distributor | buy 637774-61-9| 637774-61-9 Supplier | purchase 637774-61-9 | 637774-61-9 cost | 637774-61-9 manufacturer | order 637774-61-9 | 637774-61-9 distributor